Home » Topics » Regulatory » Patents

Patents
RSS

Ortho claims agents for osteoporosis

May 24, 1996

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

Ajinomoto reports antitumor antibiotic

May 24, 1996

Ciba-Geigy claims matrix metalloproteinase inhibitors

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

Akzo Nobel claims contraceptive vaccines

May 17, 1996

Yamanouchi claims antidiabetic agents

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...